Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 6 of 6 entries
Sorted by: Best Match Show Resources per page
Corrigendum to "A new rat model of neonatal bilirubin encephalopathy (kernicterus)" [J. Pharmacol. Toxicol. Methods 84 (2017) 44-50].

Journal of pharmacological and toxicological methods

Amini N, Vousooghi N, Soleimani M, Samadikuchaksaraei A, Akbari M, Safakheil H, Atafimanesh P, Shahbazi A, Brouki Milan P, Ramezani S, Mozafari M, Joghataei MT.
PMID: 29534860
J Pharmacol Toxicol Methods. 2018 Jul - Aug;92:95. doi: 10.1016/j.vascn.2018.02.006. Epub 2018 Mar 11.

No abstract available.

Cite
Amini N, Vousooghi N, Soleimani M, et al. Corrigendum to "A new rat model of neonatal bilirubin encephalopathy (kernicterus)" [J. Pharmacol. Toxicol. Methods 84 (2017) 44-50]. J Pharmacol Toxicol Methods. 2018;92:95doi: 10.1016/j.vascn.2018.02.006.
Amini, N., Vousooghi, N., Soleimani, M., Samadikuchaksaraei, A., Akbari, M., Safakheil, H., Atafimanesh, P., Shahbazi, A., Brouki Milan, P., Ramezani, S., Mozafari, M., & Joghataei, M. T. (2018). Corrigendum to "A new rat model of neonatal bilirubin encephalopathy (kernicterus)" [J. Pharmacol. Toxicol. Methods 84 (2017) 44-50]. Journal of pharmacological and toxicological methods, 9295. https://doi.org/10.1016/j.vascn.2018.02.006
Amini, Naser, et al. "Corrigendum to "A new rat model of neonatal bilirubin encephalopathy (kernicterus)" [J. Pharmacol. Toxicol. Methods 84 (2017) 44-50]." Journal of pharmacological and toxicological methods vol. 92 (2018): 95. doi: https://doi.org/10.1016/j.vascn.2018.02.006
Amini N, Vousooghi N, Soleimani M, Samadikuchaksaraei A, Akbari M, Safakheil H, Atafimanesh P, Shahbazi A, Brouki Milan P, Ramezani S, Mozafari M, Joghataei MT. Corrigendum to "A new rat model of neonatal bilirubin encephalopathy (kernicterus)" [J. Pharmacol. Toxicol. Methods 84 (2017) 44-50]. J Pharmacol Toxicol Methods. 2018 Jul - Aug;92:95. doi: 10.1016/j.vascn.2018.02.006. Epub 2018 Mar 11. PMID: 29534860.
Copy Download .nbib Format: NLM
A Novel Intervention Technology for Cerebral Palsy: Brain Stimulation.

Iranian journal of child neurology

Ramezani S, Amiini N, Khodaei F, Safakheil H, Sarveazad A, Mohebbi SL, Brouki Milan P.
PMID: 31037074
Iran J Child Neurol. 2019;13(2):17-28.

A common pediatric disorder with posture and motor dysfunction in neurological diseases is known as cerebral palsy (CP). Recently, a series of effective techniques have been developed for treatment of CP. These promising methods need high-tech equipment for brain...

Cite
Ramezani S, Amiini N, Khodaei F, et al. A Novel Intervention Technology for Cerebral Palsy: Brain Stimulation. Iran J Child Neurol. 2019;13(2):17-28
Ramezani, S., Amiini, N., Khodaei, F., Safakheil, H., Sarveazad, A., Mohebbi, S. L., & Brouki Milan, P. (2019). A Novel Intervention Technology for Cerebral Palsy: Brain Stimulation. Iranian journal of child neurology, 13(2), 17-28.
Ramezani, Sara, et al. "A Novel Intervention Technology for Cerebral Palsy: Brain Stimulation." Iranian journal of child neurology vol. 13,2 (2019): 17-28.
Ramezani S, Amiini N, Khodaei F, Safakheil H, Sarveazad A, Mohebbi SL, Brouki Milan P. A Novel Intervention Technology for Cerebral Palsy: Brain Stimulation. Iran J Child Neurol. 2019;13(2):17-28. PMID: 31037074; PMCID: PMC6451854.
Copy Download .nbib Format: NLM
Selective cytotoxicity mechanisms and biodistribution of diamond nanoparticles on the skin cancer in C57 mouse.

Biomedical materials (Bristol, England)

Moradi E, Naserzadeh P, Brouki Millan P, Ashtari B.
PMID: 34826833
Biomed Mater. 2021 Dec 16;17(1). doi: 10.1088/1748-605X/ac3d99.

The cytotoxicity of diamond nanoparticles (DNs) to various cell lines has been on focus by numerous scientists. The cellular toxicity system of DNs has not been fully understood or explained in skin cancer, at this point. This research was...

Cite
Moradi E, Naserzadeh P, Brouki Millan P, et al. Selective cytotoxicity mechanisms and biodistribution of diamond nanoparticles on the skin cancer in C57 mouse. Biomed Mater. 2021;17(1)doi: 10.1088/1748-605X/ac3d99.
Moradi, E., Naserzadeh, P., Brouki Millan, P., & Ashtari, B. (2021). Selective cytotoxicity mechanisms and biodistribution of diamond nanoparticles on the skin cancer in C57 mouse. Biomedical materials (Bristol, England), 17(1), . https://doi.org/10.1088/1748-605X/ac3d99
Moradi, Elham, et al. "Selective cytotoxicity mechanisms and biodistribution of diamond nanoparticles on the skin cancer in C57 mouse." Biomedical materials (Bristol, England) vol. 17,1 (2021). doi: https://doi.org/10.1088/1748-605X/ac3d99
Moradi E, Naserzadeh P, Brouki Millan P, Ashtari B. Selective cytotoxicity mechanisms and biodistribution of diamond nanoparticles on the skin cancer in C57 mouse. Biomed Mater. 2021 Dec 16;17(1). doi: 10.1088/1748-605X/ac3d99. PMID: 34826833.
Copy Download .nbib Format: NLM
Animal Kernicterus Models: Progress and Challenges.

Brain research

Amini N, Bakhshayesh Eghbali B, Ramezani S, Hosseinpour Sarmadi V, Brouki Milan P, Ashraf SS, Larijani G, Naderi Gharahgheshlagh S, Derakhshanmehr B, Mohebbi SL, Joghataei MT.
PMID: 34419443
Brain Res. 2021 Nov 01;1770:147624. doi: 10.1016/j.brainres.2021.147624. Epub 2021 Aug 20.

Kernicterus is a leading cause of neonatal death throughout the world, especially in low-middle-income countries. It is developed by an unconjugated hyperbilirubinemia in the blood and brain tissue, triggering pathological processes that spawn neurotoxicity and neurodegeneration. However, the biological...

Cite
Amini N, Bakhshayesh Eghbali B, Ramezani S, et al. Animal Kernicterus Models: Progress and Challenges. Brain Res. 2021;1770:147624doi: 10.1016/j.brainres.2021.147624.
Amini, N., Bakhshayesh Eghbali, B., Ramezani, S., Hosseinpour Sarmadi, V., Brouki Milan, P., Ashraf, S. S., Larijani, G., Naderi Gharahgheshlagh, S., Derakhshanmehr, B., Mohebbi, S. L., & Joghataei, M. T. (2021). Animal Kernicterus Models: Progress and Challenges. Brain research, 1770147624. https://doi.org/10.1016/j.brainres.2021.147624
Amini, Naser, et al. "Animal Kernicterus Models: Progress and Challenges." Brain research vol. 1770 (2021): 147624. doi: https://doi.org/10.1016/j.brainres.2021.147624
Amini N, Bakhshayesh Eghbali B, Ramezani S, Hosseinpour Sarmadi V, Brouki Milan P, Ashraf SS, Larijani G, Naderi Gharahgheshlagh S, Derakhshanmehr B, Mohebbi SL, Joghataei MT. Animal Kernicterus Models: Progress and Challenges. Brain Res. 2021 Nov 01;1770:147624. doi: 10.1016/j.brainres.2021.147624. Epub 2021 Aug 20. PMID: 34419443.
Copy Download .nbib Format: NLM
Selective cytotoxicity mechanisms and biodistribution of diamond nanoparticles on the skin cancer in C57 mouse.

Biomedical materials (Bristol, England)

Moradi E, Naserzadeh P, Brouki Millan P, Ashtari B.
PMID: 34826833
Biomed Mater. 2021 Nov 26; doi: 10.1088/1748-605X/ac3d99. Epub 2021 Nov 26.

The cytotoxicity of diamond nanoparticles (DNs) to various cell lines has been on focus by numerous scientists. The cellular toxicity system of DNs has not been fully understood or explained in skin cancer, at this point. This research was...

Cite
Moradi E, Naserzadeh P, Brouki Millan P, et al. Selective cytotoxicity mechanisms and biodistribution of diamond nanoparticles on the skin cancer in C57 mouse. Biomed Mater. 2021;doi: 10.1088/1748-605X/ac3d99.
Moradi, E., Naserzadeh, P., Brouki Millan, P., & Ashtari, B. (2021). Selective cytotoxicity mechanisms and biodistribution of diamond nanoparticles on the skin cancer in C57 mouse. Biomedical materials (Bristol, England), . https://doi.org/10.1088/1748-605X/ac3d99
Moradi, Elham, et al. "Selective cytotoxicity mechanisms and biodistribution of diamond nanoparticles on the skin cancer in C57 mouse." Biomedical materials (Bristol, England) vol. (2021). doi: https://doi.org/10.1088/1748-605X/ac3d99
Moradi E, Naserzadeh P, Brouki Millan P, Ashtari B. Selective cytotoxicity mechanisms and biodistribution of diamond nanoparticles on the skin cancer in C57 mouse. Biomed Mater. 2021 Nov 26; doi: 10.1088/1748-605X/ac3d99. Epub 2021 Nov 26. PMID: 34826833.
Copy Download .nbib Format: NLM
CRISPR-Associated (CAS) Effectors Delivery via Microfluidic Cell-Deformation Chip.

Materials (Basel, Switzerland)

Peyravian N, Malekzadeh Kebria M, Kiani J, Brouki Milan P, Mozafari M.
PMID: 34207502
Materials (Basel). 2021 Jun 09;14(12). doi: 10.3390/ma14123164.

Identifying new and even more precise technologies for modifying and manipulating selectively specific genes has provided a powerful tool for characterizing gene functions in basic research and potential therapeutics for genome regulation. The rapid development of nuclease-based techniques such...

Cite
Peyravian N, Malekzadeh Kebria M, Kiani J, et al. CRISPR-Associated (CAS) Effectors Delivery via Microfluidic Cell-Deformation Chip. Materials (Basel). 2021;14(12)doi: 10.3390/ma14123164.
Peyravian, N., Malekzadeh Kebria, M., Kiani, J., Brouki Milan, P., & Mozafari, M. (2021). CRISPR-Associated (CAS) Effectors Delivery via Microfluidic Cell-Deformation Chip. Materials (Basel, Switzerland), 14(12), . https://doi.org/10.3390/ma14123164
Peyravian, Noshad, et al. "CRISPR-Associated (CAS) Effectors Delivery via Microfluidic Cell-Deformation Chip." Materials (Basel, Switzerland) vol. 14,12 (2021). doi: https://doi.org/10.3390/ma14123164
Peyravian N, Malekzadeh Kebria M, Kiani J, Brouki Milan P, Mozafari M. CRISPR-Associated (CAS) Effectors Delivery via Microfluidic Cell-Deformation Chip. Materials (Basel). 2021 Jun 09;14(12). doi: 10.3390/ma14123164. PMID: 34207502; PMCID: PMC8226447.
Copy Download .nbib Format: NLM
Showing 1 to 6 of 6 entries